Novacyt (FR:ALNOV) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Novacyt has launched two new multiplex qPCR tests for detecting gastrointestinal diseases in cats and dogs, debuting at the London Vet Show. These tests streamline the detection of six crucial pathogens, offering faster results and efficiency for veterinary laboratories. This innovation aligns with Novacyt’s commitment to enhancing diagnostic solutions in the veterinary sector.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
